Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05512546
Other study ID # Lahore General Hospital
Secondary ID
Status Completed
Phase
First received
Last updated
Start date February 10, 2017
Est. completion date December 10, 2020

Study information

Verified date August 2022
Source Shaheed Zulfiqar Ali Bhutto Medical University
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Clopidogrel has been to be reported to be superior to aspirin for the prevention of thromboembolic complications associated with coil embolization in patients with ruptured aneurysms.


Recruitment information / eligibility

Status Completed
Enrollment 200
Est. completion date December 10, 2020
Est. primary completion date February 10, 2020
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 45 Years to 80 Years
Eligibility Inclusion Criteria: - All the patients enrolled in the study underwent MRI and Angiography. - Participants included in the study were confirmed on assessment, and verified for ruptured aneurysm by imaging using either computed tomography (CT) or MRI. Exclusion Criteria: - Patients with any history of sensitivity or reaction to aspirin, or any contraindication for MRI, were excluded from the study.

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Aspir-Low Pill
patients were prescribed 75 mg/day of either aspirin

Locations

Country Name City State
Pakistan Umair Rasheed Lahore Punjab

Sponsors (1)

Lead Sponsor Collaborator
Muhammad Hassan

Country where clinical trial is conducted

Pakistan, 

Outcome

Type Measure Description Time frame Safety issue
Primary High Intensity Areas post procedural at 24 hours
Primary High Intensity Areas Post Procedural 3 months
Secondary High Intensity Areas Post procedural at 6 months
See also
  Status Clinical Trial Phase
Completed NCT05509049 - Precision Nudging Drives Wellness Visit Attendance at Scale N/A
Active, not recruiting NCT05667974 - A Study to Evaluate a PIKA Rabies Vaccine(Vero Cell)for Human Use,Freeze-dried Phase 3
Not yet recruiting NCT06335121 - Implementation of PrEP Care Among Women in Family Planning Clinics N/A
Not yet recruiting NCT04082091 - Screening, Early Referral and Lifestyle Tailored E_prescription for Cardiovascular Prevention
Terminated NCT01395238 - Enhancing Father's Ability to Support Their Preschool Child N/A
Completed NCT00589173 - An Interactive Preventive Health Record (IPHR) to Promote Patient-Centered Preventive Care N/A
Completed NCT00535665 - Safety and Immunogenicity of an Inactivated Pandemic Influenza Vaccine Phase 2
Completed NCT00814554 - Effectiveness Evaluation of Three Strategies of Promotion of Healthy Dietary and Physical Activity Behaviours to Prevent Weight Excess Among Teenagers N/A
Completed NCT00995462 - Prevention of Weight Gain in University Students N/A
Completed NCT00966212 - Parent Education for Young Teen Females Phase 2/Phase 3
Completed NCT04526873 - Encouraging Annual Wellness Visits Among ACO Beneficiaries N/A
Recruiting NCT06112249 - SAFE Workplace Intervention for People With IDD N/A
Completed NCT04977700 - Using Physical Tracking to Predict Sunburn N/A
Completed NCT04032145 - Characterization of Health Conditions of Visitors of the Montreal Museum of Fine Arts
Completed NCT04785599 - Lymphedema Prevention After Lymph Node Emptying N/A
Recruiting NCT05050266 - Enhancing Mental and Physical Health of Women Veterans N/A
Recruiting NCT01021488 - Rosuvastatin for Preventing Deep Vein Thrombosis Phase 4
Terminated NCT02247258 - Azathioprine in the Prevention of Ileal Crohn's Disease Postoperative Recurrence. Phase 2
Recruiting NCT05903885 - A Cross-sectional Partnership to Improve Prevention N/A
Completed NCT04162977 - Adapting Personality-Targeted Interventions for Reducing Substance Misuse and Related Outcomes in Youth in Youth Protection Services N/A